Role of Pharmacogenomics in Public Health examines the impact of genetic-based personalized medicine on population health. It explores the potential for pharmacogenomics to improve drug safety, efficacy, and accessibility on a large scale. The book discusses public health strategies, policies, and ethical considerations for widespread pharmacogenomic implementation. Ideal for public health professionals and policymakers, it highlights the societal benefits of personalized medicine.
Amanda Ward explores the role of pharmacogenomics in public health to improve dermatological health outcomes at the population level. Her research focuses on implementing pharmacogenomic strategies in community health programs to personalize skin treatments and enhance overall skin health. Amanda has published extensively on the benefits of integrating pharmacogenomics into public health initiatives for conditions like acne and dermatitis. She also provides guidelines for public health professionals and clinicians to adopt pharmacogenomic approaches, promoting widespread personalized and effective dermatological care through informed public health strategies.